Novartis signs agreement to buy Avidity Biosciences for $12bn
Novartis Acquires Avidity Biosciences for $12bn Novartis has signed an agreement to acquire all outstanding shares of US-based Avidity Biosciences for $12bn in cash. The acquisition…
Compulsory voting: A remedy or ruse for democracy? - Institute of Development Studies
Compulsory Voting: A Remedy or Ruse for Democracy? The debate over compulsory voting revolves around a trade-off between participation and…
Biogen Inc.: Health Canada Grants Authorization for LEQEMBI (lecanemab) for the Treatment of Early Alzheimer's Disease
Biogen Inc.: Health Canada Grants Authorization for LEQEMBI Biogen Inc. and Eisai Co., Ltd. announced that Health Canada has issued a Noti…
IncludEd Conference: Get Inclusion Ready
IncludEd Conference: Get Inclusion Ready This January, IncludEd is hosting a conference dedicated to Whole-School Inclusion, featuring pra…
College Vidya Leads a Nationwide Celebration of Digital Learning and Inclusion: Observes Oct 25th as Online Education Day, making it India's first - Netindia123.com
College Vidya Celebrates Online Education Day College Vidya observed October 25th as Online Education Day, honoring learners, educators, a…
FIFA ASEAN Cup announced for Southeast Asia
FIFA ASEAN Cup Announced for Southeast Asia The tournament was announced during the 47th ASEAN Summit in Kuala Lumpur. FIFA and ASEAN have…
Remarks On Assam CM | Gauhati High Court Extends Interim Protection Granted To Journalist Abhisar Sharma Till November 17
Gauhati High Court Extends Interim Protection for Journalist Abhisar Sharma The Gauhati High Court has extended interim protection for jou…
Mid-Engined Yaris Makes Belated Super Taikyu Debut – Sportscar365
Mid-Engined Yaris Makes Belated Super Taikyu Debut The Toyota GR Yaris M Concept made its delayed race debut at the Okayama International …
Dolly Dimpley (Smiling Friends) | Know Your Meme
Dolly Dimpley (Smiling Friends) Dolly Dimpley refers to an OC character on the YouTube channel Critter Clipz 2002, who is inserted into cl…
Kyverna Therapeutics, Inc.: Kyverna Therapeutics Highlights Potential of KYV-101 in Rheumatoid Arthritis with Phase 1 Data from Investigator-Initiated Trial Presented at ACR Convergence 2025
Kyverna Therapeutics, Inc. Kyverna Therapeutics Highlights Potential of KYV-101 in Rheumatoid Arthritis with Phase 1 Data from Investigato…
Cullinan Therapeutics, Inc.: Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025
Cullinan Therapeutics Presents Preclinical Data for CLN-978 Cullinan Therapeutics, Inc. (Nasdaq: CGEM) will present new preclinical data f…